1. Sun SJ, Xi Y, eds. Antibacterial drug therapy. 1st ed. Beijing: People's Medical Publishing House;2008:428–434.
2. Ma Y, Li JY, Zhang XM, Zhang L, Hu CQ, Jin SH. Antimicrobial resistance of clinical bacteria in national surveillance network in 2002. Chin J Lab Med (Chin) 2004;27:38–45.
3. Cao B. Antimicrobial treatment against pneumonia with multidrug-resistant gram-negative bacteria. Chin J Respir Crit Care Med (Chin) 2008;7:3–5.
4. Sun JY, Ni YX, Wang F, Zhu DM, Hu FP, Ruan FY, et al. CHINET 2007 surveillance of antimicrobial resistance in Pseudomonas aeruginosa in China. Chin J Infect Chemother (Chin) 2009;9:192–195.
5. Lee SY, Kotapati S, Kuti JL, Nightingale CH, Nicolau DP. Impact of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study. Infect Control Hosp Epidemiol 2006;27:1226–1232.